Pharmaceutical testing company Inotiv faces an investigation into whether its monkey-sourcing practices may have violated the US foreign bribery law.
The SEC has sent Inotiv a request for documents and information relating to the company’s and several subsidiaries’ importation of “non-human primates” from Asia, including whether its practices comply with